| abstract |
The present invention provides a preventive and / or therapeutic agent for a disease involving cannabinoid 2 receptor (CB2). Formula (I) (Wherein V is O, OH; R 1 is H, CF 3 , aliphatic hydrocarbon, etc .; R 2 is H, halogen, aliphatic hydrocarbon, etc .; R 3 is a mono- to tricyclic carbocycle, aryl W is N, S; n is 0-2; R 4 and R 4 ′ are H, aliphatic hydrocarbons; R 5 and R 6 are H, trihalomethanesulfonyl, etc .; ring P and ring Q are alicyclic Heterohydrocarbon groups, etc.), salts thereof, solvates thereof, and pharmaceutical compositions containing these as active ingredients. [Selection figure] None |